Jacobs Levy Equity Management, Inc Corcept Therapeutics Inc Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,349,682 shares of CORT stock, worth $94.4 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
1,349,682
Previous 1,376,881
1.98%
Holding current value
$94.4 Million
Previous $69.4 Million
122.19%
% of portfolio
0.65%
Previous 0.27%
Shares
12 transactions
Others Institutions Holding CORT
# of Institutions
472Shares Held
84.3MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.16 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$698 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$541 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$429 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$271 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.49B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...